Literature DB >> 26700792

Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.

Stephen V Faraone1, Ann Childress2, Sharon B Wigal3, Scott H Kollins4, Mary Ann McDonnell5, Norberto J DeSousa6, F Randy Sallee6.   

Abstract

OBJECTIVE: Children with ADHD frequently manifest behavioral difficulties in the morning prior to school. We sought to assess the reliability and validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised (DPREMB-R) morning score as a measure of morning behaviors impaired by ADHD.
METHOD: We used data from a clinical trial of HLD200 treatment in pediatric participants with ADHD to address our objectives.
RESULTS: The DPREMB-R morning score showed significant internal homogeneity, test-retest reliability ( r = .52-.45), and good concurrent validity ( r = .50-.71).
CONCLUSION: The DPREMB-R morning score could be a useful instrument for assessing treatment efficacy in the morning before school.

Entities:  

Keywords:  ADHD; DPREMB-R; before school; children and adolescents; functioning; morning; reliability; validity

Mesh：

Substances：

Year:  2015        PMID： 26700792     DOI： 10.1177/1087054715619009

Source DB:  PubMed          Journal:  J Atten Disord        ISSN： 1087-0547            Impact factor:   3.256


  4 in total

1.  Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder.

Authors:  Steven R Pliszka; Timothy E Wilens; Samantha Bostrom; Valerie K Arnold; Andrea Marraffino; Andrew J Cutler; Frank A López; Norberto J DeSousa; Floyd R Sallee; Bev Incledon; Jeffrey H Newcorn
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-21       Impact factor: 2.576

2.  Outcome domains and outcome measures used in studies assessing the effectiveness of interventions to manage non-respiratory sleep disturbances in children with neurodisabilities: a systematic review.

Authors:  Catriona McDaid; Adwoa Parker; Arabella Scantlebury; Caroline Fairhurst; Vicky Dawson; Heather Elphick; Catherine Hewitt; Gemma Spiers; Megan Thomas; Bryony Beresford
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

3.  A Randomized, Double-Blind, Placebo-Controlled Study of HLD200, a Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder: An Evaluation of Safety and Efficacy Throughout the Day and Across Settings.

Authors:  Ann C Childress; Andrew J Cutler; Andrea Marraffino; Mary Ann McDonnell; John M Turnbow; Matthew Brams; Norberto J DeSousa; Bev Incledon; Floyd R Sallee; Sharon B Wigal
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-08-29       Impact factor: 2.576

4.  Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate.

Authors:  Timothy E Wilens; Stephen V Faraone; Paul G Hammerness; Steven R Pliszka; Cassandra L Uchida; Norberto J DeSousa; Floyd R Sallee; Bev Incledon; Jeffrey H Newcorn
Journal:  J Atten Disord       Date:  2021-06-04       Impact factor: 3.256
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.